Anders Gülfe

2020

Anti-rheumatic treatment and prosthetic joint infection: An observational study in 494 elective hip and knee arthroplasties

Borgas, Y., Gülfe, A., Kindt, M. & Stefánsdóttir, A., 2020 juni 29, I: BMC Musculoskeletal Disorders. 21, 1, 410.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

2018

Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis

Olofsson, T., Söderling, J. K., Gülfe, A., Kristensen, L. E. & Wallman, J. K., 2018, I: Arthritis Care and Research. 70, 11, s. 1712-1716 5 s.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2016

EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors: a prospective cohort study from southern Sweden.

Gülfe, A., KARLSSON WALLMAN, J. & Kristensen, L. E., 2016, I: Arthritis Research and Therapy. 18, 1, 51.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-Dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade

Cooper, A., KARLSSON WALLMAN, J. & Gülfe, A., 2016, I: Scandinavian Journal of Rheumatology. 45, 6, s. 470-473 4 s.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2015

Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.

Andréasson, K., Jönsson, G., Lindell, P., Gülfe, A., Ingvarsson, R., Lindqvist, E., Saxne, T., Grankvist, A., Wennerås, C. & Marsal, J., 2015, I: Rheumatology. 54, 2, s. 369-371

Forskningsoutput: Tidskriftsbidrag › Letter

2014

Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.

Gülfe, A., C Kapetanovic, M. & Kristensen, L. E., 2014, I: Scandinavian Journal of Rheumatology. 43, 6, s. 493-497

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort

Kristensen, L. E., Bliddal, H., Christensen, R., Karlsson, J., Gülfe, A., Saxne, T. & Geborek, P., 2014, I: Arthritis Care and Research. 66, 2, s. 173-179

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

2013

Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures

Berthold, E., Geborek, P. & Gülfe, A., 2013 okt., I: Acta Orthopaedica. 84, 5, s. 495-501 7 s.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

Fil

208 Nedladdningar (Pure)

2012

Individualized outcome measures of daily activities are sensitive tools for evaluating hand surgery in rheumatic diseases.

Malcus Johnsson, P., Sandqvist, G., Sturesson, A.-L., Gülfe, A., Kopylov, P., Tägil, M. & Geborek, P., 2012, I: Rheumatology (Oxford, England).

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2011

National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.

Karlsson, J., Nilsson, J.-Å., Neovius, M., Kristensen, L. E., Gülfe, A., Saxne, T. & Geborek, P., 2011, I: Annals of the Rheumatic Diseases. 70, s. 2163-2166

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2010

Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.

Gülfe, A., Kristensen, L. E., Saxne, T., Jacobsson, L., Petersson, I. & Geborek, P., 2010, I: Annals of the Rheumatic Diseases. 69, 2, s. 352-357

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Fil

124 Nedladdningar (Pure)

Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.

Gülfe, A., Kristensen, L. E., Saxne, T., Jacobsson, L., Petersson, I. & Geborek, P., 2010, I: Arthritis Care and Research. 62, 10, s. 1399-1406

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2009

Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

Gülfe, A., Aletaha, D., Saxne, T. & Geborek, P., 2009, I: BMC Musculoskeletal Disorders. 10

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Measure for measure. Outcome assessment of arthritis treatment in clinical practice

Gülfe, A., 2009, Clinical Sciences, Lund University. 115 s.

Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Fil

245 Nedladdningar (Pure)

Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden.

Gülfe, A., Kristensen, L. E. & Geborek, P., 2009, I: Journal of Rheumatology. 36, s. 517-521

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

2008

Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register.

Kristensen, L. E., Gülfe, A., Saxne, T. & Geborek, P., 2008, I: Annals of the Rheumatic Diseases. 67, s. 364-369

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Fil

206 Nedladdningar (Pure)

Health utilities improvement during TNF blockade in chronic arthritis occurs early in the treatment course, results from an eight year observational study in southern Sweden

Gülfe, A., Kristensen, L. E., Saxne, T., Jacobsson, L., Petersson, I. & Geborek, P., 2008, I: Arthritis and Rheumatism. 58, 9, s. S552-S552

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.

Kristensen, L. E., Kapetanovic, M. C., Gülfe, A., Söderlin, M., Saxne, T. & Geborek, P., 2008, I: Rheumatology (Oxford, England). 47, 4, s. 495-499

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.

Karlsson, J., Kristensen, L. E., C Kapetanovic, M., Gülfe, A., Saxne, T. & Geborek, P., 2008, I: Rheumatology. 47, 4, s. 507-513

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

2005

No increase of severe infections in RA patients treated with TNF-blockers

Jacobsson, L. T. H., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I., Saxne, T. & Geborek, P., 2005, I: Annals of the Rheumatic Diseases. 64, Suppl. 3, s. 461-462

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

Response criteria for rheumatoid arthritis in clinical practice - how useful are they?

Gülfe, A., Geborek, P. & Saxne, T., 2005, I: Annals of the Rheumatic Diseases. 64, 8, s. 1186-1189

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

Fil

176 Nedladdningar (Pure)

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M., Petersson, I., Saxne, T. & Geborek, P., 2005, I: Journal of Rheumatology. 32, 7, s. 1213-1218

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

Geborek, P., Bladström, A., Turesson, C., Gülfe, A., Petersson, I. F., Saxne, T., Olsson, H. & Jacobsson, L., 2005, I: Annals of the Rheumatic Diseases. 64, 5, s. 699-703

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

2001

Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis

Månsson, B., Gülfe, A., Geborek, P., Heinegård, D. & Saxne, T., 2001, I: Annals of the Rheumatic Diseases. 60, 1, s. 27-31

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Öppen tillgång

1997

Allvarlig biverkning av metotrexat vid reumatoid artrit. Glöm ej säkerhetsrutiner vid interkurrent sjukdom!

Gülfe, A. & Sturfelt, G., 1997, I: Läkartidningen. 94, 19, s. 1811-1812

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Anders Gülfe

Forskningsoutput

Sökresultat